Benralizumab efficacy and safety in severe asthma: A randomized trial in Asia

Author:

Lai Kefang,Sun Dejun,Dai Ranran,Samoro Ronnie,Park Hae-Sim,Åstrand Annika,Cohen David,Jison Maria,Shih Vivian H.ORCID,Werkström Viktoria,Yao Yuhui,Zhang Yajuan,Zheng Wenying,Zhong Nanshan

Funder

AstraZeneca PLC

Publisher

Elsevier BV

Reference25 articles.

1. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma;Chung;Eur. Respir. J.,2014

2. Epidemiology of asthma in children and adults;Dharmage;Front Pediatr.,2019

3. Changing trends and challenges in the management of asthma in Asia;Song;J. Allergy Clin. Immunol.,2017

4. Prevalence, risk factors, and management of asthma in China: a national cross-sectional study;Huang;Lancet,2019

5. [A cross-section study of severe asthma in eight provinces of China];Su;Zhonghua Nei Ke Za Zhi,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3